BioMADE has released a national survey showing broad US public support for expanding domestic bioindustrial manufacturing.
The survey, conducted in partnership with YouGov, found that Americans across regions, demographics and political affiliations want more bio-based products in supply chains, support federal investment in biomanufacturing, and want the US to remain globally competitive in the sector.
BioMADE said the findings point to strong public backing for strategic action as China, India and the European Union increase investment in biomanufacturing capacity.
Support for bio-based products and federal investment
According to the survey, 56% of Americans said they want more American-made, bio-based products available on store shelves and in the supply chain, while 5% disagreed.
Six in ten respondents said the US Government should invest in biomanufacturing research and production to reduce reliance on foreign supply chains and strengthen national competitiveness. Again, 5% disagreed.
The survey also found that 59% of Americans believe the US must fight to remain a global leader and avoid falling behind China, India and the EU in biomanufacturing.
“The results of this survey confirm what we are seeing and hearing across the country: bioindustrial manufacturing has the power to create jobs people want, support domestic supply chains, and reduce U.S. reliance on foreign imports,” said Douglas Friedman, Chief Executive Officer at BioMADE.
“The majority of Americans aren’t only open to federal investment to win this critical industry, they are expecting it.”
Global competition in biomanufacturing
BioMADE said the survey comes as other major economies scale their own bioindustrial manufacturing strategies.
The organisation pointed to China’s annual biomanufacturing investment, India’s plans to expand facilities and double the economic impact of its sector by 2030, and Europe’s larger fermentation capacity compared with the US.
Bioindustrial manufacturing uses biological systems to produce goods including chemicals, materials, textiles, fuels, bioplastics and other products. BioMADE’s bioindustrial manufacturing page says the sector can create domestic supply chains for everyday products while opening new markets for agricultural feedstocks and waste streams.
Pilot plant network aims to close scale-up gap
BioMADE said it is working with more than 300 members across 41 states to strengthen US competitiveness, reshore manufacturing jobs and develop a 21st-century bioindustrial workforce.
The organisation is also developing a Pilot Plant Network of pilot-scale bioindustrial manufacturing facilities designed to help move products from the lab into commercial and defence markets.
BioMADE was catalysed by the US Department of Defense in October 2020 and is part of Manufacturing USA.
Read more clean manufacturing coverage in Climate Global News’ Manufacturing & Recycling and Technology & Innovation sections.
FAQs
What did the BioMADE survey find?
The survey found broad support for more American-made bio-based products, federal investment in biomanufacturing and US leadership in the global bioindustrial manufacturing sector.
Who conducted the survey?
The survey was conducted in partnership with YouGov.
What is bioindustrial manufacturing?
Bioindustrial manufacturing uses biological systems to convert feedstocks and waste streams into products such as chemicals, materials, textiles, fuels and bioplastics.
What is BioMADE?
BioMADE is a Manufacturing USA institute focused on strengthening US bioindustrial manufacturing, supply chains, workforce development and pilot-scale infrastructure.
